Cost-effectiveness considerations in chemoprevention of cancer.
Habbema
J D
JD
Department of Public Health, Faculty of Medicine, Erasmus University Rotterdam, The Netherlands.
van der Heide
A
A
van den Bosch
J M
JM
Bonneux
L
L
D000328:Adult; D000368:Aged; D016588:Anticarcinogenic Agents / Q000191:economics / Q000627:therapeutic use; D018890:Chemoprevention / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000517:prevention & control*
D016588:Anticarcinogenic Agents